X-One A Tablet 5/80/20 mg
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
MFDS item code 202005383 · Approved 2020.07.24 · Insurance code 640007670
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular diseases (such as myocardial infarction)
This medication is used in patients who require simultaneous administration of amlodipine/valsartan combination therapy and atorvastatin. The amlodipine/valsartan combination is effective for patients with essential hypertension who have difficulty controlling blood pressure with amlodipine or valsartan alone. Atorvastatin is used to reduce the risk of cardiovascular diseases and is also effective for treating dyslipidemia. In particular, it helps reduce the risk of myocardial infarction, stroke, revascularization, and angina, and supports the treatment of various types of hypercholesterolemia and dyslipidemia. This drug is used to effectively control blood pressure and blood lipid levels to improve heart and vascular health.
Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate products may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, direct conversion to the amlodipine/valsartan combination may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. It may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at treatment initiation and to assess response to treatment. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are unavailable. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. - Elderly patients: The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in the general adult patient population.
This medication may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately upon confirmation of pregnancy. If muscle-related diseases or markedly elevated muscle enzyme levels occur, the intake of this drug should be stopped, and patients at high risk of myopathy should be especially cautious. This medication should not be used in patients with certain allergies or severely impaired liver or kidney function, as well as in women who are pregnant or breastfeeding. Caution should be exercised when administering to patients with hypotension, fluid depletion, hyperkalemia, renal artery stenosis, etc., and consultation with a physician is recommended prior to administration in such cases. Patients with heart failure or those recovering from myocardial infarction or with certain heart conditions need special caution when taking this medication. During the course of treatment with this drug, regular monitoring of liver function, kidney function, blood pressure, and muscle condition should be conducted, and any abnormal symptoms should be reported to a doctor immediately. Caution is required while driving or operating machinery as dizziness or fatigue may occur. This drug may interact with several other medications, so be sure to inform your doctor or pharmacist if you are taking other medications, particularly certain antibiotics, antifungals, immunosuppressants, or some heart medications. Women who are pregnant or planning to conceive should consult a doctor before taking this medication and must use appropriate contraception methods; breastfeeding women are also advised to avoid taking this medication. Some ingredients in this medication contain lactose, so patients with lactose intolerance should consult a doctor before use. If symptoms like muscle pain, weakness, or fever arise, consult a doctor immediately to check for muscle damage and receive necessary treatment. If hepatitis symptoms or severe skin rashes, swelling, etc. appear while taking this medication, discontinue use immediately and inform healthcare personnel.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius. This will help maintain the effectiveness of the medication for a longer time.
Light orange oval film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Dong Gu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.